Insulin resistance is a systemic disorder, in which there is a reduced action of insulin despite an “hyperinsulinaemia” condition, that affects many organs, in particular the liver and adipose tissue, and leads to development of two NCDs, type 2 diabetes mellitus (T2DM) and metabolic syndrome, well known cardiovascular risk factors. This evidence concerns the gene INS and type 2 diabetes mellitus.